CLFB-1134

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCLFB-1134
Drug Alias Namesecond generation MLK-3 inhibitors (Califia)CLFB-1134
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitogen-activated protein kinase kinase kinase 11 inhibitors
TargetsMitogen-activated protein kinase kinase kinase 11
Therapy Area/IndicationsParkinson DiseaseMultiple SclerosisAIDS Dementia Complex
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCalifia Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCalifia Bio Inc
Active IndicationsN/A
Inactive IndicationsParkinson DiseaseMultiple SclerosisAIDS Dementia Complex

Other Information

ATC CodeN/A
Related LinksN/A